The Direct Answer
AI M&A regulatory planning should begin before a target is formally marketed, not after a buyer submits an antitrust filing or receives a regulator’s questionnaire. Buyers evaluating an AI company need to understand what the product actually does, which data it uses, how it makes decisions, whether those decisions affect people’s employment, credit, health, housing, education, or access to essential services, and whether the transaction changes control over valuable technology, data, compute, users, or distribution. A useful plan separates four questions: Can the company operate lawfully, can the product be transferred, can the deal clear competition review, and could the buyer continue the service without recreating regulatory exposure? These are related but different risks.
Also worth reading: How should founders navigate AI legal compliance for startups in the current 2026 regulatory environment? · How Should AI Startup Founders Plan for Dilution Before Raising Their Next Round? · How can founders and operators assess AI investment risk in private deals?
The planning baseline must be jurisdiction-specific. The United States has no single, permanent federal AI code comparable to the European Union’s AI framework, while states, agencies, and courts continue to impose or interpret rules affecting particular uses. Canada also has a developing federal and provincial framework, which matters in a Canada–U.S. transaction because obligations can arise on both sides of the border. A transaction involving a New York model developer and a Toronto customer-data platform, for example, may require analysis under U.S. federal antitrust law, applicable state privacy or automated-decision laws, Canadian commercial and privacy rules, and contractual restrictions. The correct objective is not to eliminate every possible challenge; it is to identify issues early enough that management can choose a defensible structure, price the uncertainty, allocate risk, or decline.
How AI Changes Traditional M&A Diligence
Conventional M&A diligence usually focuses on financial statements, customer contracts, intellectual property, litigation, employees, tax, and data security. AI diligence adds questions that are technical, behavioral, and regulatory at once. Buyers must determine whether training, evaluation, retrieval, and deployment data were lawfully obtained; whether the company’s claims about model accuracy are reproducible; whether generated content creates copyright or publicity-right exposure; and whether the target has adequate controls against prompt injection, model extraction, poisoned datasets, and unauthorized use of third-party tools. A clean corporate chart does not answer whether a product makes legally consequential decisions about identifiable people.
The buyer should also test how the system fails. A model with a 95% aggregate accuracy rate can still create material exposure if the remaining errors occur in hiring, medical triage, credit assessment, or another high-impact use. The evaluation should therefore report error rates by subgroup, language, geography, and relevant operating condition rather than relying on one overall benchmark. For a recruiting model, a buyer may examine false-negative rates, adverse-impact measures, notice procedures, human review, and the employer’s ability to contest an automated result. For a customer-service agent, the questions may center on consent, recording rules, identity verification, and whether the agent represents itself as a person.
AI diligence must extend beyond the target’s own model. Vendors, cloud providers, data licensors, annotation contractors, and orchestration software can determine whether the business can continue operating after closing. Contract diligence should establish who owns fine-tuned weights, embeddings, prompts, evaluation data, and derived artifacts, and whether a service agreement permits transfer to the buyer. Technical dependencies should be mapped to business continuity. A target that depends on one external model API, one scarce compute contract, or one proprietary data license may have a lower valuation than its headline growth rate suggests.
Building the Regulatory Risk Map
The first planning document should be a regulatory map organized by product, use, jurisdiction, and transaction structure. Start with the target’s revenue streams and identify which features are general-purpose tools versus regulated or high-impact applications. For each feature, record the customer population, data categories, decision rights, human involvement, geographic reach, and contractual promises. This prevents an overly broad label such as “AI company” from substituting for actual analysis. An internal productivity assistant used by 30 employees is not equivalent to software scoring applicants for federally regulated loans, even if both rely on similar foundation models.
Antitrust analysis is equally specific. The relevant question is not merely whether the parties are large, but whether the target owns or controls a technology, data set, distribution channel, or platform that would be difficult to replicate. In a vertical acquisition, the buyer may gain access to sensitive inputs, improve its product using competitor data, or foreclose rival developers. Horizontal combinations require close attention to market definition, concentration, switching costs, and the availability of substitutes. Agencies may also investigate theories involving data, compute, talent, ecosystems, or control of an essential input; however, no numerical concentration threshold guarantees clearance or identifies a safe harbor. Merger guidelines are evidence for a risk analysis, not a substitute for product-market facts.
The map should assign an owner and a confidence level to every issue. “Unknown” is more useful than a vague statement that compliance is “in progress,” because unknowns can be converted into diligence requests and modeled scenarios. A red issue might be a pending claim alleging systematic discriminatory hiring outcomes; an amber issue might be an international deployment with changing automated-decision requirements; and a green issue might be a documented internal tool with no personal-data use. The classification should be reviewed with counsel and technical experts rather than delegated to a generic questionnaire.
A Practical Transaction Workplan
A practical process begins with a two-week or three-week issue-spotting sprint, followed by deeper work before exclusivity. During the sprint, management identifies the target’s products, jurisdictions, customer categories, data flows, model providers, material claims, and pending government contacts. Counsel then prepares a jurisdiction and transaction matrix, while the technical team runs a reproducible model and data review. The output is not a full legal opinion; it is a ranked list of facts that could affect price, structure, timing, conditions, or closing certainty.
After the initial review, management should test at least three deal structures: acquisition of the operating company, acquisition of selected assets, or a commercial partnership followed by a later acquisition. It should also compare a full acquisition with a minority investment structured to preserve operational separation, although contractual governance rights and information rights may still create competition concerns. A consent structure, data-transfer covenant, remediation plan, or escrow may address identified risk, but it cannot legalize conduct that a regulator or court later treats as unlawful. The business should state what evidence is required before each proposed protection is considered adequate.
The buyer should maintain an issue register from the first diligence call through integration. Each entry should include the underlying fact, legal or operational question, evidence, probability of occurrence, potential financial range, responsible executive, mitigation, and decision date. High-probability, high-impact issues should reach the investment committee before the purchase agreement is finalized. For a smaller transaction, external specialists can be engaged for defined tasks, but using fewer advisers does not justify skipping model testing or data-chain verification. Integration planning should begin at diligence stage because the target’s product roadmap, customer promises, and data practices may change after closing.
Comparing the Main Transaction Options
There is no universally best structure for an AI acquisition. A full acquisition offers control and immediate access to talent, intellectual property, and customers, but it also transfers liabilities and may create the strongest competition concerns. An asset purchase can limit selected liabilities and make contract transfers clearer, but customers, employees, and licenses may not move automatically. A minority investment may reduce closing risk and preserve optionality, but it may not deliver the operational control sought by the buyer.
| Feature | Full acquisition | Asset or staged transaction | Minority investment or partnership |
|---|---|---|---|
| Control | Broad control over business, IP, and roadmap | Control can be focused on selected assets or capabilities | Usually limited control; rights depend on financing and governance terms |
| Regulatory exposure | Broadest transfer of historical, product, and data-related exposure | Can permit focused diligence and stronger separation, but transfer gaps may impair value | May reduce immediate control-related concerns, while information and coordination rights still require review |
| Speed | Potentially slower due to broader diligence and approvals | Can be faster if contracts and IP transfer cleanly | Often useful for validation before committing to a larger transaction |
| Integration | Greater ability to combine products, data, and teams | More complex migration and licensing work | Lower immediate integration burden but weaker ability to capture synergies |
| Best fit | Buyer confident it can operate and integrate the whole business | Buyer needs a defined capability or uncertain legacy exposure | Parties need market validation or a staged learning period |
Common Mistakes That Create Expensive Delay
One common mistake is treating model benchmarks as proof of legal compliance. A benchmark measures performance under a particular test condition; it does not establish lawful data processing, adequate disclosure, consumer consent, or meaningful human review. Another is assuming that because a model vendor offers safeguards, the deploying company has no responsibility. In many arrangements, the deployer decides the purpose, audience, inputs, consequences, and escalation process, so responsibility cannot be assigned entirely to a model provider.
Buyers also make the mistake of waiting for a regulator to define the market. By the time an agency requests information, the parties may have exchanged sensitive plans, committed integration resources, or signed restrictive interim arrangements. A second error is underestimating ordinary-course operations. A pre-closing product launch can alter the competitive picture, and a post-closing change in data use can create a new issue even if the original deal was defensible. The transaction agreement should address operating covenants, required approvals, notice of investigations, product changes, data deletion or migration, and cooperation after closing.
A third mistake is relying on a promise that a problem will be “fixed after closing.” Remediation may require retraining, deleting data, obtaining consents, changing customer contracts, rebuilding an evaluation process, or suspending a feature. Those actions can delay revenue and reduce customer retention. Remediation costs should be modeled by function: engineering effort, outside specialists, expected downtime, customer credits, legal fees, and the possibility that a product must be withdrawn. The most credible plan identifies the decision gate at which the buyer will spend money, the evidence needed before spending, and the point at which it should abandon the transaction.
When to Act and How to Budget the Work
Regulatory planning should start before a banker approaches the target, but the intensity should scale with risk and deal value. A small internal-tools acquisition may be manageable with focused legal, technical, and privacy review. A cross-border acquisition of a foundation-model company, healthcare platform, or consumer data business warrants specialist advice and a formal integration plan. As a broad planning reference, many transactions can use a staged approach covering the initial issue spot, product and data review, regulatory assessment, and negotiation support; the budget is driven more by system complexity and jurisdictions than by a fixed hourly menu.
External diligence commonly includes a data-protection review, an AI-specific technical assessment, model red-team testing, an intellectual-property chain-of-title review, and competition analysis. A large or sensitive transaction can cost substantially more than a conventional software diligence exercise because the team must examine training data, third-party licenses, compute arrangements, safety cases, high-impact use cases, and historical marketing claims. Investors should request estimates broken down by workstream, assumptions, deliverables, and specialist qualifications rather than accepting an undefined “AI risk fee.” Cloud and software testing can be inexpensive or free in some cases, but human legal and domain review cannot be replaced by purchasing an automated scanning tool.
Timing should be measured against the transaction calendar. A review completed 10 business days before signing may identify serious problems too late to negotiate a structure; a review started six months before signing may delay the process without a decision. The practical objective is to reach an informed go, restructure, reprice, or no-go decision at the point when the buyer still has leverage. For the Mercer Club network, the relevant value is access to experienced operators and founders who can test these assumptions against real deal histories, not a promise that a transaction will be automatically safe or automatically prohibited.
The Decision Standard for a Buyer
The best AI M&A regulatory plan produces a documented decision, not a collection of cautionary memos. It should tell the investment committee which risks are resolved, which are bounded by contract or structure, which remain open, and which would make the expected value unacceptable. A buyer can proceed when it understands the product’s real-world uses, can reproduce important performance claims, has verified data and IP rights, has a workable competition position, and has priced the cost of compliance and integration. None of these conditions eliminates litigation or agency scrutiny, but each reduces avoidable uncertainty.
Regulatory risk is often commercially manageable rather than binary. A company may acquire a target while limiting the acquired scope, delaying a restricted feature, separating data pools, maintaining an independent governance committee, or agreeing to specific reporting and security measures. Those options should be compared against the cost of walking away. The decisive question is whether the buyer can operate the acquired business lawfully and profitably under conditions it understands, not whether the technology is labeled AI. In 2026, early planning is most effective when it combines legal analysis with technical testing, commercial judgment, and explicit decision dates.
As a final control, the board or investment committee should receive a one-page risk statement alongside the full diligence record. The statement should name the three most consequential issues, their estimated financial effect, the evidence supporting each estimate, the proposed mitigation, and the event that would change the recommendation. This keeps sophisticated AI compliance from becoming an abstract exercise. It also gives the deal team a shared standard for deciding whether to sign, renegotiate, pause, or exit.